Case report
Nov 2026
Innovative Management of Non-HLA Antibody and NK Cell-Mediated Rejection After Kidney Transplantation With Imlifidase: A Case Report.
Integrating dd-cfDNA, transcriptomic biopsy analysis, and non-HLA antibody assessment may optimize the management of highly sensitized KT recipients following imlifidase induction, however, long-term efficacy remains to be confirmed.
F. von Tokarski, Marion Rabant, V. Goutaudier et al.
· American Journal of Kidney D... · 0 citations